The medical story and advice comes from Swiss Policy Research article On the Treatment of Covid-19. This is what primary care physicians are recommending in many parts of the world, and what should be the generally accepted practice everywhere. Excerpts in italics with my bolds.
Based on the available scientific evidence and current clinical experience, the SPR Collaboration recommends that physicians and authorities consider the following covid-19 treatment protocol for the prophylactic and early treatment of people at high risk or high exposure.
Numerous international studies have shown that prophylactic and early treatment can significantly reduce the risk of severe or fatal covid-19 (see scientific references in linked article).
Note: Patients are asked to consult a doctor.
- Zinc (25mg to 50mg per day)
- Quercetin (250mg to 500mg per day)
- Bromhexine (24mg to 36mg per day)*
- Vitamin D (2000 IU per day)
- Vitamin C (1000mg per day)
- Zinc (75mg to 150mg per day)
- Quercetin (500mg to 1000mg per day)
- Vitamins D (5000 u/d) and C (1000mg/d)
- Bromhexine (50mg to 100mg per day)*
- Aspirin (162mg to 325mg per day)*
- Ivermectin (12mg per day for 2 days)*
- High-dose vitamin D (up to 100,000 IU)
- Azithromycin (up to 500mg per day)
- Prednisone (60mg to 80mg per day)*
- Hydroxychloroquine (400mg per day)*
Contraindications for aspirin and bromhexine must be observed. Ivermectin may also be used prophylactically on a weekly basis. Prednisone is to be used if pulmonary symptoms develop. Correctly dosed HCQ has been shown to be effective and safe for the early treatment of covid-19.
Modes of action
- Zinc inhibits RNA polymerase activity of coronaviruses and thus blocks virus replication, as first discovered by world-leading SARS virologist Ralph Baric in 2010.
- Ivermectin (an antiparasitic drug) has strong anti-viral and anti-inflammatory properties.
- Quercetin (a plant polyphenol) supports the cellular absorption of zinc and has additional anti-viral properties, as first discovered during the SARS-1 epidemic in 2003.
- Bromhexine (a mucolytic cough medication) inhibits the expression of cellular TMPRSS2 protease and thus the entry of the virus into the cell, as first described in 2017.
- Vitamins C and D support and improve the immune system response to infections.
- Aspirin may help prevent infection-related thrombosis and embolisms in patients at risk.
- Azithromycin (an antibiotic) prevents bacterial superinfections of the lung.
- Prednisone (a corticosteroid) reduces covid-related systemic inflammation.
- HCQ has known anti-viral, anti-thrombotic and anti-inflammatory properties.
The early treatment of patients as soon as the first typical symptoms appear and even without a PCR test is essential to prevent progression of the disease. In contrast, isolating infected high-risk patients at home and without early treatment until they develop serious respiratory problems, as often happened during lockdowns, may be counterproductive.
People at high risk living in an epidemically active area should consider prophylactic treatment together with their doctor. The reason for this is the long incubation period of covid-19 (up to 14 days): when patients first notice that they contracted the disease, the viral load is already at a maximum and there are often only a few days left to react with an early treatment intervention.
Early treatment based on the above protocol is intended to avoid hospitalization. If hospitalization nevertheless becomes necessary, experienced ICU doctors recommend avoiding invasive ventilation (intubation) whenever possible and using oxygen therapy (HFNC) instead.
It is conceivable that the above treatment protocol, which is simple, safe and inexpensive, could render more complex medications, vaccinations, and other measures largely obsolete.
Footnote: New Ivermectin Results
Dr Andrew Hill of the Department of Pharmacology at the University of Liverpool (UK) is currently performing a WHO-commissioned review and meta-analysis of randomized controlled trials of ivermectin against covid. In the following 12-minute video, Dr Hill is presenting his preliminary results, which confirm a highly significant 83% reduction in covid mortality (95% CI 65%-92%).
This result is based on in-hospital trials, so it doesn’t even take into account early ambulatory and prophylactic treatment. The WHO now wants to wait for three more trials, due to be published sometime in January, before issuing an official recommendation. At the end of his presentation, Dr Hill speaks of ivermectin as a potentially “transformational treatment”.
Note: Use video setting to select english subtitles.
I wouldn’t presume to judge winners and losers among societies coping with this strange virus: so infectious and not dangerous to most people while deadly to some. I do note that the response was different in more remote and poorer places. Treatment decisions were taken by doctors close to their sick patients, without the burden of bureaucracies obsessed with high tech Big Pharma silver bullet vaccines. Physicians in many parts of the world scrambled to provide anti-viral medicines and immune-enhancing nutritional supplements, whatever they could get their hands on. An example is Dominican Republic, small island nation depending on tourism, so not isolated. Dr. Redondo:
“After eight months of active clinical observation and attending about 7 thousand patients of Covid-19 in three medical centers located in Puerto Plata, La Romana, and Punta Cana, Dr. José Natalio Redondo revealed that 99.3% of the symptomatic patients who received care in his emergency services, including the use of Ivermectin, managed to recover in the first five days of recorded symptoms.”
“The renowned cardiologist and health manager affirmed that Ivermectin’s use against the symptoms of Covid-19 is practically generalized in the country and attributed to this factor, among others, the fact that the risk of dying from this disease in the Dominican Republic is significantly lower than in the United States.”
He added that “in a therapeutic format duly tested over the years, infections have always been cured faster and leave fewer sequelae if antimicrobial treatment is applied as early as possible since this allows the use of lower doses of the selected drugs. This has been one of the dogmas that remain in our daily medical practice.”
“From the beginning, our team of medical specialists, who were at the forefront of the battle, led by our emergency physicians, intensivists and internists, raised the need to see this disease in a different way than that proposed by international health organizations,” says Dr. Redondo in his report.
And he adds that the Group’s experts proposed the urgency of reorienting the management protocols towards earlier and more timely stages. “We realized that the war was being lost because of the obsession of large groups, agencies, and companies linked to research and production of drugs, to focus their interest almost exclusively on the management of critical patients.
“Our results were immediate; the use of Ivermectin, together with Azithromycin and Zinc (plus the usual vitamins that tend to increase the immune response of individuals) produced an impressive variation in the course of the disease; it was demonstrated that 99.3% of the patients recovered quickly when the treatment was started in the first five days of proven symptoms, with an average of 3.5 days, and a fall of more than 50% in the rate and duration of hospitalizations, and reducing from 9 to 1 the mortality rate, when the treatment was started on time.”
This is not about HCL or Ivermectin. In any society family physicians and local clinics are the key to preventative medicine. For Covid, so-called “advanced” societies ruled out safe, effective, inexpensive and available treatments that made the contagion manageable.
But the successes of such unsung heroes in many far away places are also ruled out of social media and 24/7 cable news.
See also: The Case for Ivermectin Covid Regimen